Pacific Beach BioSciences Licenses Novel Fluoroquinolone From Korean Firm Dong Wha
This article was originally published in PharmAsia News
Executive Summary
Pacific Beach BioSciences, a San Diego start-up, and Dong Wha Pharmaceutical have signed a development and commercialization deal for zabofloxacin, a novel fluoroquinolone antibiotic discovered by the Korean pharma, the companies announced Aug. 10